img

Global Poliovirus Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Poliovirus Vaccine Market Insights, Forecast to 2034

Polio vaccines are vaccines used to prevent poliomyelitis (polio).
Global Poliovirus Vaccine market is expected to reach to US$ 737.9 million in 2024, with a positive growth of %, compared with US$ 709.8 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Poliovirus Vaccine industry is evaluated to reach US$ 955.4 million in 2029. The CAGR will be 4.4% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Poliovirus Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Poliovirus Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

Segment by Application


Public
Private

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Poliovirus Vaccine plant distribution, commercial date of Poliovirus Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Poliovirus Vaccine introduction, etc. Poliovirus Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Poliovirus Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Poliovirus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Poliovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market by Application
1.3.1 Global Poliovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Poliovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Poliovirus Vaccine Revenue by Region
2.2.1 Global Poliovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Poliovirus Vaccine Revenue by Region (2018-2024)
2.2.3 Global Poliovirus Vaccine Revenue by Region (2024-2029)
2.2.4 Global Poliovirus Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Poliovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Poliovirus Vaccine Sales by Region
2.4.1 Global Poliovirus Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Poliovirus Vaccine Sales by Region (2018-2024)
2.4.3 Global Poliovirus Vaccine Sales by Region (2024-2029)
2.4.4 Global Poliovirus Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Poliovirus Vaccine Sales by Manufacturers
3.1.1 Global Poliovirus Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Poliovirus Vaccine in 2022
3.2 Global Poliovirus Vaccine Revenue by Manufacturers
3.2.1 Global Poliovirus Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Poliovirus Vaccine Revenue in 2022
3.3 Global Key Players of Poliovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Poliovirus Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Poliovirus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Poliovirus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Poliovirus Vaccine Sales by Type
4.1.1 Global Poliovirus Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Poliovirus Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Poliovirus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Poliovirus Vaccine Revenue by Type
4.2.1 Global Poliovirus Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Poliovirus Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Poliovirus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Poliovirus Vaccine Price by Type
4.3.1 Global Poliovirus Vaccine Price by Type (2018-2024)
4.3.2 Global Poliovirus Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Poliovirus Vaccine Sales by Application
5.1.1 Global Poliovirus Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Poliovirus Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Poliovirus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Poliovirus Vaccine Revenue by Application
5.2.1 Global Poliovirus Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Poliovirus Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Poliovirus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Poliovirus Vaccine Price by Application
5.3.1 Global Poliovirus Vaccine Price by Application (2018-2024)
5.3.2 Global Poliovirus Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Poliovirus Vaccine Market Size by Type
6.1.1 US & Canada Poliovirus Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Poliovirus Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Poliovirus Vaccine Market Size by Application
6.2.1 US & Canada Poliovirus Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Poliovirus Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Poliovirus Vaccine Market Size by Country
6.3.1 US & Canada Poliovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Poliovirus Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Poliovirus Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Poliovirus Vaccine Market Size by Type
7.1.1 Europe Poliovirus Vaccine Sales by Type (2018-2029)
7.1.2 Europe Poliovirus Vaccine Revenue by Type (2018-2029)
7.2 Europe Poliovirus Vaccine Market Size by Application
7.2.1 Europe Poliovirus Vaccine Sales by Application (2018-2029)
7.2.2 Europe Poliovirus Vaccine Revenue by Application (2018-2029)
7.3 Europe Poliovirus Vaccine Market Size by Country
7.3.1 Europe Poliovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Poliovirus Vaccine Sales by Country (2018-2029)
7.3.3 Europe Poliovirus Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Poliovirus Vaccine Market Size
8.1.1 China Poliovirus Vaccine Sales (2018-2029)
8.1.2 China Poliovirus Vaccine Revenue (2018-2029)
8.2 China Poliovirus Vaccine Market Size by Application
8.2.1 China Poliovirus Vaccine Sales by Application (2018-2029)
8.2.2 China Poliovirus Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Poliovirus Vaccine Market Size by Type
9.1.1 Asia Poliovirus Vaccine Sales by Type (2018-2029)
9.1.2 Asia Poliovirus Vaccine Revenue by Type (2018-2029)
9.2 Asia Poliovirus Vaccine Market Size by Application
9.2.1 Asia Poliovirus Vaccine Sales by Application (2018-2029)
9.2.2 Asia Poliovirus Vaccine Revenue by Application (2018-2029)
9.3 Asia Poliovirus Vaccine Sales by Region
9.3.1 Asia Poliovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Poliovirus Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Poliovirus Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Poliovirus Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Poliovirus Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Poliovirus Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Poliovirus Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Poliovirus Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Poliovirus Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 GSK Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Company Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bibcol Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Company Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Serum Institute Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Company Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Tiantan Biological Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Company Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 IMBCA Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Company Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Panacea Biotec Ltd Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Company Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bio-Med Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Company Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Poliovirus Vaccine Industry Chain Analysis
12.2 Poliovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Poliovirus Vaccine Production Mode & Process
12.4 Poliovirus Vaccine Sales and Marketing
12.4.1 Poliovirus Vaccine Sales Channels
12.4.2 Poliovirus Vaccine Distributors
12.5 Poliovirus Vaccine Customers
13 Market Dynamics
13.1 Poliovirus Vaccine Industry Trends
13.2 Poliovirus Vaccine Market Drivers
13.3 Poliovirus Vaccine Market Challenges
13.4 Poliovirus Vaccine Market Restraints
14 Key Findings in The Global Poliovirus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Poliovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 4. Global Poliovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Poliovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Poliovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Poliovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Poliovirus Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Poliovirus Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Poliovirus Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Poliovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Poliovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Poliovirus Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Poliovirus Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Poliovirus Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Poliovirus Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Poliovirus Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Poliovirus Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Poliovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Poliovirus Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2022)
Table 23. Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Poliovirus Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Poliovirus Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Poliovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Poliovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Poliovirus Vaccine Sales Share by Type (2018-2024)
Table 30. Global Poliovirus Vaccine Sales Share by Type (2024-2029)
Table 31. Global Poliovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Poliovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Poliovirus Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Poliovirus Vaccine Revenue Share by Type (2024-2029)
Table 35. Poliovirus Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Poliovirus Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Poliovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Poliovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Poliovirus Vaccine Sales Share by Application (2018-2024)
Table 40. Global Poliovirus Vaccine Sales Share by Application (2024-2029)
Table 41. Global Poliovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Poliovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Poliovirus Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Poliovirus Vaccine Revenue Share by Application (2024-2029)
Table 45. Poliovirus Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Poliovirus Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Poliovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Poliovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Poliovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Poliovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Poliovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Poliovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Poliovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Poliovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Poliovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Poliovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Poliovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Poliovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Poliovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Poliovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Poliovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Poliovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Poliovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Poliovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Poliovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Poliovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Poliovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Poliovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Poliovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Poliovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Poliovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Poliovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Poliovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Poliovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Poliovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Poliovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Poliovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Poliovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Poliovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Poliovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Poliovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Poliovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Poliovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Poliovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Poliovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Poliovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Poliovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Poliovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Poliovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Poliovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Poliovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Poliovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Poliovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Poliovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Poliovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Poliovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Poliovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Poliovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Poliovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Poliovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Poliovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. GSK Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Bibcol Company Information
Table 118. Bibcol Description and Major Businesses
Table 119. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Bibcol Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bibcol Recent Developments
Table 122. Serum Institute Company Information
Table 123. Serum Institute Description and Major Businesses
Table 124. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Serum Institute Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Serum Institute Recent Developments
Table 127. Tiantan Biological Company Information
Table 128. Tiantan Biological Description and Major Businesses
Table 129. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Tiantan Biological Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tiantan Biological Recent Developments
Table 132. IMBCA Company Information
Table 133. IMBCA Description and Major Businesses
Table 134. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. IMBCA Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. IMBCA Recent Developments
Table 137. Panacea Biotec Ltd Company Information
Table 138. Panacea Biotec Ltd Description and Major Businesses
Table 139. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Panacea Biotec Ltd Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Panacea Biotec Ltd Recent Developments
Table 142. Bio-Med Company Information
Table 143. Bio-Med Description and Major Businesses
Table 144. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Bio-Med Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bio-Med Recent Developments
Table 147. Halfkin Bio-Pharmaceuticals Company Information
Table 148. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 149. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Halfkin Bio-Pharmaceuticals Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Poliovirus Vaccine Distributors List
Table 155. Poliovirus Vaccine Customers List
Table 156. Poliovirus Vaccine Market Trends
Table 157. Poliovirus Vaccine Market Drivers
Table 158. Poliovirus Vaccine Market Challenges
Table 159. Poliovirus Vaccine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Poliovirus Vaccine Product Picture
Figure 2. Global Poliovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Poliovirus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Polio Vaccine (IPV) Product Picture
Figure 5. Oral Polio Vaccine (OPV) Product Picture
Figure 6. Global Poliovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Poliovirus Vaccine Market Share by Application in 2022 & 2029
Figure 8. Public
Figure 9. Private
Figure 10. Poliovirus Vaccine Report Years Considered
Figure 11. Global Poliovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Poliovirus Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Poliovirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Poliovirus Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Poliovirus Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Poliovirus Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Poliovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Poliovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Poliovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Poliovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Poliovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Poliovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Poliovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Poliovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Poliovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Poliovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Poliovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Poliovirus Vaccine in the World: Market Share by Poliovirus Vaccine Revenue in 2022
Figure 29. Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Poliovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Poliovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Poliovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Poliovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Poliovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Poliovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Poliovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Poliovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Poliovirus Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Poliovirus Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Poliovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Poliovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Poliovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Poliovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Poliovirus Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Poliovirus Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. UK Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Poliovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Poliovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Poliovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Poliovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Poliovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Poliovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Poliovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Poliovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Poliovirus Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Poliovirus Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Poliovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Poliovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Poliovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Poliovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Poliovirus Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Poliovirus Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Poliovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Poliovirus Vaccine Value Chain
Figure 80. Poliovirus Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries